Related Experiment Videos
Amiodarone-induced thyroid disorders: a clinical review
1Endocrine Unit, Department of Medicine, Tan Tock Seng Hospital, Singapore 308433.
Postgraduate Medical Journal
|February 23, 2000
Summary
Amiodarone, an anti-arrhythmic drug, can affect thyroid function due to its iodine content. This can lead to amiodarone-induced hypothyroidism or thyrotoxicosis, requiring specific management strategies based on the type.
Area of Science:
- Endocrinology
- Cardiology
- Pharmacology
Background:
- Amiodarone is a potent anti-arrhythmic medication.
- Its high iodine content can disrupt thyroid function and hormone metabolism.
- Patients may experience altered thyroid profiles, hypothyroidism, or thyrotoxicosis.
Purpose of the Study:
- To review the mechanisms and clinical presentations of amiodarone-induced thyroid dysfunction.
- To outline management strategies for amiodarone-induced hypothyroidism and thyrotoxicosis.
- To discuss the impact of dietary iodine on the prevalence of these conditions.
Main Methods:
- Literature review of amiodarone's effects on thyroid function.
- Analysis of clinical manifestations and etiological factors.
- Summary of treatment options for different types of amiodarone-induced thyroid disorders.
Main Results:
- Amiodarone can cause hypothyroidism via the Wolff-Chaikoff effect, prevalent in high-iodine areas, managed by drug cessation or hormone replacement.
- Amiodarone-induced thyrotoxicosis (AIT) is more common in low-iodine areas.
- AIT presents as Type I (excessive synthesis) or Type II (destructive thyroiditis), requiring distinct treatments (thionamides/perchlorate for Type I, glucocorticoids for Type II).
Conclusions:
- Understanding the distinct types of amiodarone-induced thyroid dysfunction is crucial for appropriate management.
- Treatment strategies should be tailored to the specific type of thyroid dysfunction and local iodine intake.
- Surgery is a potential option for select patients requiring long-term amiodarone therapy.